Cargando…

Performance of 3 mL versus 5 mL Discarded Volume for Blood Sampling from Central Venous Access Device

Background Central venous access devices (CVAD) are an essential part of safe practices in critical care, which enable effective venous access and help in avoiding repeated venipuncture. Discard method is widely practiced for blood sampling. A single occasion of blood sampling may cause minimal blo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lalthanthuami, HT, Kumari, MJ, Venkateswaran, R, Lakshmi, PR, Ramamoorthy, Lakshmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409120/ https://www.ncbi.nlm.nih.gov/pubmed/34483554 http://dx.doi.org/10.1055/s-0041-1726669

Ejemplares similares

Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL
por: de la Peña, Amparo, et al.
Publicado: (2015)

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
por: Lew, Mark F., et al.
Publicado: (2021)

Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature
por: Vargas-Uricoechea, Hernando
Publicado: (2018)

In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
por: Schiavon, Michele, et al.
Publicado: (2020)

AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cycles
por: Dashtipour, Khashayar, et al.
Publicado: (2020)

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial
por: Bolli, Geremia B., et al.
Publicado: (2021)

Ocular Tolerability of Bimatoprost 0.1 mg/mL Preservative-Free versus Bimatoprost 0.1 mg/mL with Benzalkonium Chloride or Bimatoprost 0.3 mg/mL Preservative-Free in Patients with Primary Open-Angle Glaucoma
por: Filippelli, Mariaelena, et al.
Publicado: (2022)

Measurement of the kaon mass difference $m_L -m_S$ by the two regenerator method
por: Geweniger, C, et al.
Publicado: (1974)

Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin (rDNA origin) in 0.9% sodium chloride ready‐to‐use infusion 1 U/mL and 100 U/mL concentrate diluted to 1 U/mL in healthy males
por: Hompesch, Marcus, et al.
Publicado: (2021)

Hepatic Arterial Phase on Gadoxetic Acid-Enhanced Liver MR Imaging: A Randomized Comparison of 0.5 mL/s and 1 mL/s Injection Rates
por: Kim, Sung Mo, et al.
Publicado: (2014)

The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS
por: Adegun, Patrick Temi, et al.
Publicado: (2015)

Comparative evaluation of anesthetic efficacy of 1.8 mL and 3.6 mL of articaine in irreversible pulpitis of the mandibular molar: A randomized clinical trial
por: Silva, Stella Agra, et al.
Publicado: (2019)

Long‐term Stability of a Compounded Suspension of Torsemide (5 mg/mL) for Oral Administration
por: Adin, D., et al.
Publicado: (2017)

Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis in Pancreatic Cancer: A Prospective Pilot Study of Safety Using 10 mL versus 20 mL Alcohol
por: LeBlanc, Julia K., et al.
Publicado: (2013)

Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
por: Kovatchev, Boris, et al.
Publicado: (2020)

Bioavailability study of Enoxaparin Sodium Chemi (80 mg/0.8 mL) and Clexane (80 mg/0.8 mL) subcutaneous injection in healthy adults
por: Febbraro, Salvatore, et al.
Publicado: (2021)

‘Walking epidural’: comparison of the analgesic efficacy of levobupivacaine 0.0625% + fentanyl 2mcg/mL versus ropivacaine 0.075% + fentanyl 2mcg/mL
por: Mingote, Álvaro, et al.
Publicado: (2023)

Can men with prostates sized 80 mL or larger be managed conservatively?
por: Lee, Alvin, et al.
Publicado: (2017)

Nocturnal Glycemic Control with New Insulin Glargine 300 U/mL
por: Yu, Neng Chun
Publicado: (2019)

Spotted wolffish (Anarhichas minor) sperm cryopreservation in 5-mL cryovials
por: Beirão, J., et al.
Publicado: (2020)

Efficacy of holmium laser enucleation in patients with a small (less than 30 mL) prostate volume
por: Tsuboi, Ichiro, et al.
Publicado: (2021)

Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysis
por: Sugiyama, Kazutoshi, et al.
Publicado: (2019)

Clinical utility of serum folate measurement in tertiary care patients: Argument for revising reference range for serum folate from 3.0 ng/mL to 13.0 ng/mL
por: Singh, Gurmukh, et al.
Publicado: (2015)

Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study
por: Cheng, Alice, et al.
Publicado: (2019)

Rapid 500 mL albumin bolus versus rapid 200 mL bolus followed by slower continuous infusion in post-cardiac surgery patients: a pilot before-and-after study
por: Yanase, Fumitaka, et al.
Publicado: (2023)

Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects
por: Woodley, Wendy D., et al.
Publicado: (2021)

Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4)
por: Home, Philip D., et al.
Publicado: (2017)

Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis
por: Nakanishi, Shuhei, et al.
Publicado: (2018)

Evaluation of Patient Reported Satisfaction and Clinical Efficacy of Insulin Glargine 300 U/mL Versus 100 U/mL in Patients With Type 1 Diabetes Using Flash Glucose Monitoring System
por: Al Hayek, Ayman Abdullah, et al.
Publicado: (2022)

Prostatic volume determination by transabdominal ultrasonography: Does accuracy vary significantly with urinary bladder volumes between 50 to 400 mL?
por: Brakohiapa, Edmund K., et al.
Publicado: (2019)

Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial
por: Haluzík, Martin, et al.
Publicado: (2020)

THU073 Somapacitan Administered Subcutaneously At 5 mg/1.5 mL Or 10 mg/1.5 mL Strengths Yields Clinically Similar PK And IGF-I Profiles In Healthy Participants
por: Rasmussen, Michael Højby, et al.
Publicado: (2023)

Volumizing effects of a smooth, highly cohesive, viscous 20-mg/mL hyaluronic acid volumizing filler: prospective European study
por: Hoffmann, Klaus
Publicado: (2009)

Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
por: Lee, Seung Hwan, et al.
Publicado: (2011)

AB050. Laparoscopic transperitoneal enucleation of the prostate for benigh prostatic hyperplasia >80 mL
por: Feng, Ning-Han
Publicado: (2015)

Anticoagulant properties of enoxaparin 400 IU/mL–40 % ethanol catheter lock solution
por: Calvet, Laure, et al.
Publicado: (2015)

Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL
por: Calcagno, Andrea, et al.
Publicado: (2014)

Insulin glargine 300 U/mL in the management of diabetes: clinical utility and patient perspectives
por: de Galan, Bastiaan E
Publicado: (2016)

Efficacy of Holmium Laser Enucleation of the Prostate in Patients with a Small Prostate (≤30 mL)
por: Park, Sejun, et al.
Publicado: (2017)

Insulin depot absorption modeling and pharmacokinetic simulation with insulin glargine 300 U/mL
por: Lindauer, Klaus, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6feqqdrpl1ltinase5p79rioig